Thrombotic microangiopathies

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    The thrombotic microangiopathies (TMs) are a group of diseases that share the qualities of thrombocytopenia and microangiopathic hemolytic anemia resulting in microvascular occlusion and end-organ damage. The classic TMs are thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Since the early days of transplantation, it has been noted many patients developed a TM-type disease that was often fulminant and fatal. Research has been difficult due to lack of standardization of diagnostic criteria, and much controversy remains about the best therapy.

    Original languageEnglish (US)
    Title of host publicationBlood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care
    PublisherSpringer New York
    Pages261-264
    Number of pages4
    ISBN (Print)9781441975058
    DOIs
    StatePublished - 2011

    Fingerprint

    Thrombotic Microangiopathies
    Thrombotic Thrombocytopenic Purpura
    Hemolytic-Uremic Syndrome
    Hemolytic Anemia
    Thrombocytopenia
    Transplantation
    Research
    Therapeutics

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Deloughery, T. (2011). Thrombotic microangiopathies. In Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care (pp. 261-264). Springer New York. https://doi.org/10.1007/978-1-4419-7506-5_22

    Thrombotic microangiopathies. / Deloughery, Thomas.

    Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, 2011. p. 261-264.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Deloughery, T 2011, Thrombotic microangiopathies. in Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, pp. 261-264. https://doi.org/10.1007/978-1-4419-7506-5_22
    Deloughery T. Thrombotic microangiopathies. In Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York. 2011. p. 261-264 https://doi.org/10.1007/978-1-4419-7506-5_22
    Deloughery, Thomas. / Thrombotic microangiopathies. Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care. Springer New York, 2011. pp. 261-264
    @inbook{3f82229bc5874cd3921754d577f832c5,
    title = "Thrombotic microangiopathies",
    abstract = "The thrombotic microangiopathies (TMs) are a group of diseases that share the qualities of thrombocytopenia and microangiopathic hemolytic anemia resulting in microvascular occlusion and end-organ damage. The classic TMs are thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Since the early days of transplantation, it has been noted many patients developed a TM-type disease that was often fulminant and fatal. Research has been difficult due to lack of standardization of diagnostic criteria, and much controversy remains about the best therapy.",
    author = "Thomas Deloughery",
    year = "2011",
    doi = "10.1007/978-1-4419-7506-5_22",
    language = "English (US)",
    isbn = "9781441975058",
    pages = "261--264",
    booktitle = "Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care",
    publisher = "Springer New York",

    }

    TY - CHAP

    T1 - Thrombotic microangiopathies

    AU - Deloughery, Thomas

    PY - 2011

    Y1 - 2011

    N2 - The thrombotic microangiopathies (TMs) are a group of diseases that share the qualities of thrombocytopenia and microangiopathic hemolytic anemia resulting in microvascular occlusion and end-organ damage. The classic TMs are thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Since the early days of transplantation, it has been noted many patients developed a TM-type disease that was often fulminant and fatal. Research has been difficult due to lack of standardization of diagnostic criteria, and much controversy remains about the best therapy.

    AB - The thrombotic microangiopathies (TMs) are a group of diseases that share the qualities of thrombocytopenia and microangiopathic hemolytic anemia resulting in microvascular occlusion and end-organ damage. The classic TMs are thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Since the early days of transplantation, it has been noted many patients developed a TM-type disease that was often fulminant and fatal. Research has been difficult due to lack of standardization of diagnostic criteria, and much controversy remains about the best therapy.

    UR - http://www.scopus.com/inward/record.url?scp=84892285603&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84892285603&partnerID=8YFLogxK

    U2 - 10.1007/978-1-4419-7506-5_22

    DO - 10.1007/978-1-4419-7506-5_22

    M3 - Chapter

    SN - 9781441975058

    SP - 261

    EP - 264

    BT - Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care

    PB - Springer New York

    ER -